All persons or entities who or which, during the period from May 11, 2021 through October 19, 2021, inclusive, purchased or otherwise acquired the publicly traded common stock of Novavax, Inc. and were damaged thereby.
Preliminarily Approved
May 11, 2021 - October 19, 2021
May 23, 2024
May 02, 2024
Novavax, Inc. Securities Settlement c/o Strategic Claims Services, Inc. 600 N. Jackson Street, Suite 205 P.O. Box 230 Media, PA 19063 www.strategicclaims.net/novavax/
Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.